Clinical relevance of JAK2 (V617F) mutant allele burden

被引：60
|
作者：
Passamonti, Francesco [1 ]
Rumi, Elisa [1 ]
机构：
[1] Univ Pavia, Fdn IRCCS Policlin San Matteo, Div Hematol, I-27100 Pavia, Italy
来源：
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL | 2009年 / 94卷 / 01期
关键词：
POLYCYTHEMIA-VERA; ESSENTIAL THROMBOCYTHEMIA; WILD-TYPE; MUTATION; JAK2V617F; MYELOFIBROSIS; JAK2(V617F); RISK; PROGRESSION; GRANULOCYTE;
D O I：
10.3324/haematol.2008.001271
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：7 / 10
页数：4
相关论文
共 50 条
  • [1] Quantitative Method for the Assessment of JAK2 V617F Mutant Allele Burden
    Bissaillon, C. M.
    Rios, K. M.
    Label, K. A.
    Tsongalis, G. J.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2014, 16 (06): : 722 - 722
  • [2] The JAK2 V617F mutational status and allele burden
    Liang, Shanshan
    Zhou, Yanhong
    THROMBOSIS RESEARCH, 2015, 136 (03) : 690 - 690
  • [3] JAK2 V617F ALLELE BURDEN IN CHRONIC MYELOPROLIFERATIVE DISEASES
    Skerget, Matevz
    Pajic, Tadej
    Kralj, Eva
    Vuckovic, Josko
    ZDRAVNISKI VESTNIK-SLOVENIAN MEDICAL JOURNAL, 2008, 77 : I57 - I61
  • [4] JAK2, the JAK2 V617F mutant and cytokine receptors
    Staerk, J.
    Kallin, A.
    Royer, Y.
    Diaconu, C. C.
    Dusa, A.
    Demoulin, J.-B.
    Vainchenker, W.
    Constantinescu, S. N.
    PATHOLOGIE BIOLOGIE, 2007, 55 (02): : 88 - 91
  • [5] DOES ALLELE BURDEN IMPORT IN MYELOFIBROSIS WITH JAK2 V617F MUTATION?
    Maria Isabel, Montero Cuadrado
    Francisco Jose, Marquez Malaver
    Cruz Estrella, Carrillo
    Canale Silvia, Garcia
    Lucia, Mezquita
    Javier, Delgado
    Caro Rocio, Marin
    Francisco Jose, Martin Dominguez
    Nancy, Rodriguez
    Campos Jose, Gonzalez
    Jose Francisco, Falantes
    Jose Antonio, Perez Simon
    HAEMATOLOGICA, 2021, 106 (10) : 258 - 258
  • [6] The JAK2 V617F mutational status and allele burden - authors' reply
    Borowczyk, Martyna
    Wojtaszewska, Marzena
    Lewandowski, Krzysztof
    Gil, Lidia
    Lewandowska, Maria
    Lehmann-Kopydlowska, Agata
    Kroll-Balcerzak, Renata
    Balcerzak, Andrzej
    Iwola, Malgorzata
    Michalak, Michal
    Komarnicki, Mieczyslaw
    THROMBOSIS RESEARCH, 2015, 136 (03) : 691 - 692
  • [7] Limited Efficacy of Hydroxyurea in Lowering of the JAK2 V617F Allele Burden
    Larsen, Thomas Stauffer
    Pallisgaard, Niels
    de Stricker, Karin
    Moller, Michael Boe
    Hasselbalch, Hans Carl
    BLOOD, 2008, 112 (11) : 617 - 618
  • [8] Limited efficacy of hydroxyurea in lowering of the JAK2 V617F allele burden
    Larsen, Thomas Stauffer
    Pallisgaard, Niels
    de Stricker, Karin
    Moller, Michael Boe
    Hasselbalch, Hans Carl
    HEMATOLOGY, 2009, 14 (01) : 11 - 15
  • [9] Clinical features and outcomes of JAK2 V617F-positive polycythemia vera and essential thrombocythemia according to the JAK2 V617F allele burden
    Lee, A-Jin
    Kim, Sang-Gyung
    Nam, Jun Yeb
    Yun, Jaehum
    Ryoo, Hun-Mo
    Bae, Sung Hwa
    BLOOD RESEARCH, 2021, 56 (04) : 259 - 265
  • [10] IMPACT OF THE JAK2 (V617F) MUTATION AND THE MUTANT ALLELE BURDEN ON DISEASE PROGRESSION IN CHRONIC MYELOPROLIFERATIVE DISORDERS
    Passamonti, F.
    Rumi, E.
    Pietra, D.
    Boveri, E.
    Pascutto, C.
    Lazzarino, M.
    Cazzola, M.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 : 298 - 299
12345